Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

GLPG vs DBVT vs ALKS vs PRGO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
GLPG
Galapagos N.V.

Biotechnology

HealthcareNASDAQ • BE
Market Cap$1.83B
5Y Perf.-86.3%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-58.8%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+116.4%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.61B
5Y Perf.-78.6%

GLPG vs DBVT vs ALKS vs PRGO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
GLPG logoGLPG
DBVT logoDBVT
ALKS logoALKS
PRGO logoPRGO
IndustryBiotechnologyBiotechnologyBiotechnologyDrug Manufacturers - Specialty & Generic
Market Cap$1.83B$1712.35T$5.90B$1.61B
Revenue (TTM)$1.11B$0.00$1.56B$4.18B
Net Income (TTM)$321M$-168M$153M$-1.82B
Gross Margin56.0%65.4%34.2%
Operating Margin26.7%12.3%-4.1%
Forward P/E4.9x24.8x5.6x
Total Debt$7M$22M$70M$3.97B
Cash & Equiv.$88M$194M$1.12B$532M

GLPG vs DBVT vs ALKS vs PRGOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

GLPG
DBVT
ALKS
PRGO
StockMay 20May 26Return
Galapagos N.V. (GLPG)10013.7-86.3%
DBV Technologies S.… (DBVT)10041.2-58.8%
Alkermes plc (ALKS)100216.4+116.4%
Perrigo Company plc (PRGO)10021.4-78.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: GLPG vs DBVT vs ALKS vs PRGO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: GLPG leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. DBV Technologies S.A. is the stronger pick specifically for recent price momentum and sentiment. PRGO also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
GLPG
Galapagos N.V.
The Growth Play

GLPG carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.

  • Rev growth 303.5%, EPS growth 333.0%, 3Y rev CAGR 66.4%
  • Lower volatility, beta 0.74, Low D/E 0.2%, current ratio 20.15x
  • Beta 0.74, current ratio 20.15x
  • 303.5% revenue growth vs DBVT's -100.0%
Best for: growth exposure and sleep-well-at-night
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT is the #2 pick in this set and the best alternative if momentum is your priority.

  • +110.4% vs PRGO's -51.2%
Best for: momentum
ALKS
Alkermes plc
The Long-Run Compounder

ALKS is the clearest fit if your priority is long-term compounding.

  • -11.0% 10Y total return vs GLPG's -41.9%
Best for: long-term compounding
PRGO
Perrigo Company plc
The Income Pick

PRGO is the clearest fit if your priority is income & stability.

  • Dividend streak 10 yrs, beta 1.18, yield 9.8%
  • 9.8% yield; 10-year raise streak; the other 3 pay no meaningful dividend
Best for: income & stability
See the full category breakdown
CategoryWinnerWhy
GrowthGLPG logoGLPG303.5% revenue growth vs DBVT's -100.0%
ValueGLPG logoGLPGLower P/E (4.9x vs 24.8x)
Quality / MarginsGLPG logoGLPG28.9% margin vs PRGO's -43.5%
Stability / SafetyGLPG logoGLPGBeta 0.74 vs DBVT's 1.26, lower leverage
DividendsPRGO logoPRGO9.8% yield; 10-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs PRGO's -51.2%
Efficiency (ROA)GLPG logoGLPG8.3% ROA vs DBVT's -89.0%

GLPG vs DBVT vs ALKS vs PRGO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

GLPGGalapagos N.V.
FY 2022
Upfront payments and milestone payments
66.6%$174M
Jyseleca
33.4%$88M
DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B

GLPG vs DBVT vs ALKS vs PRGO — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLGLPGLAGGINGALKS

Income & Cash Flow (Last 12 Months)

GLPG leads this category, winning 4 of 6 comparable metrics.

PRGO and DBVT operate at a comparable scale, with $4.2B and $0 in trailing revenue. GLPG is the more profitable business, keeping 28.9% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, GLPG holds the edge at +10.9% YoY revenue growth, suggesting stronger near-term business momentum.

MetricGLPG logoGLPGGalapagos N.V.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
RevenueTrailing 12 months$1.1B$0$1.6B$4.2B
EBITDAEarnings before interest/tax$244M-$112M$212M$58M
Net IncomeAfter-tax profit$321M-$168M$153M-$1.8B
Free Cash FlowCash after capex-$266M-$151M$392M$108M
Gross MarginGross profit ÷ Revenue+56.0%+65.4%+34.2%
Operating MarginEBIT ÷ Revenue+26.7%+12.3%-4.1%
Net MarginNet income ÷ Revenue+28.9%+9.8%-43.5%
FCF MarginFCF ÷ Revenue-23.9%+25.1%+2.6%
Rev. Growth (YoY)Latest quarter vs prior year+10.9%+28.2%-7.2%
EPS Growth (YoY)Latest quarter vs prior year+40.0%+91.5%-4.1%-56.4%
GLPG leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 3 of 5 comparable metrics.

At 4.9x trailing earnings, GLPG trades at a 80% valuation discount to ALKS's 24.8x P/E. On an enterprise value basis, GLPG's 2.8x EV/EBITDA is more attractive than ALKS's 17.3x.

MetricGLPG logoGLPGGalapagos N.V.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
Market CapShares × price$1.8B$1712.35T$5.9B$1.6B
Enterprise ValueMkt cap + debt − cash$1.7B$1712.35T$4.9B$5.1B
Trailing P/EPrice ÷ TTM EPS4.87x-0.76x24.76x-1.14x
Forward P/EPrice ÷ next-FY EPS est.5.56x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple2.75x17.25x7.42x
Price / SalesMarket cap ÷ Revenue1.40x4.00x0.38x
Price / BookPrice ÷ Book value/share0.48x0.66x3.28x0.55x
Price / FCFMarket cap ÷ FCF12.28x11.12x
PRGO leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

GLPG leads this category, winning 5 of 9 comparable metrics.

GLPG delivers a 11.2% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-130 for DBVT. GLPG carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRGO's 1.35x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs PRGO's 4/9, reflecting strong financial health.

MetricGLPG logoGLPGGalapagos N.V.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
ROE (TTM)Return on equity+11.2%-130.2%+8.8%-50.7%
ROA (TTM)Return on assets+8.3%-89.0%+5.4%-19.8%
ROICReturn on invested capital+12.5%+18.9%+3.7%
ROCEReturn on capital employed+14.2%-145.7%+14.2%+4.3%
Piotroski ScoreFundamental quality 0–96474
Debt / EquityFinancial leverage0.00x0.13x0.04x1.35x
Net DebtTotal debt minus cash-$81M-$172M-$1.0B$3.4B
Cash & Equiv.Liquid assets$88M$194M$1.1B$532M
Total DebtShort + long-term debt$7M$22M$70M$4.0B
Interest CoverageEBIT ÷ Interest expense11.29x-189.82x32.30x-7.20x
GLPG leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — DBVT and ALKS each lead in 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, DBVT leads with a +110.4% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs PRGO's -25.2% — a key indicator of consistent wealth creation.

MetricGLPG logoGLPGGalapagos N.V.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
YTD ReturnYear-to-date-15.9%+4.9%+25.3%-13.5%
1-Year ReturnPast 12 months+7.5%+110.4%+16.5%-51.2%
3-Year ReturnCumulative with dividends-34.0%+19.7%+14.5%-58.1%
5-Year ReturnCumulative with dividends-63.0%-69.1%+60.9%-60.1%
10-Year ReturnCumulative with dividends-41.9%-87.0%-11.0%-77.7%
CAGR (3Y)Annualised 3-year return-12.9%+6.2%+4.6%-25.2%
Evenly matched — DBVT and ALKS each lead in 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — GLPG and ALKS each lead in 1 of 2 comparable metrics.

GLPG is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricGLPG logoGLPGGalapagos N.V.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
Beta (5Y)Sensitivity to S&P 5000.74x1.26x1.06x1.18x
52-Week HighHighest price in past year$37.78$26.18$36.60$28.44
52-Week LowLowest price in past year$24.74$7.53$25.17$9.23
% of 52W HighCurrent price vs 52-week peak+73.4%+76.3%+96.7%+41.2%
RSI (14)Momentum oscillator 0–10046.348.160.260.9
Avg Volume (50D)Average daily shares traded165K252K2.3M3.4M
Evenly matched — GLPG and ALKS each lead in 1 of 2 comparable metrics.

Analyst Outlook

PRGO leads this category, winning 1 of 1 comparable metric.

Analyst consensus: GLPG as "Hold", DBVT as "Buy", ALKS as "Buy", PRGO as "Hold". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 19.0% for GLPG (target: $33). PRGO is the only dividend payer here at 9.81% yield — a key consideration for income-focused portfolios.

MetricGLPG logoGLPGGalapagos N.V.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
Analyst RatingConsensus buy/hold/sellHoldBuyBuyHold
Price TargetConsensus 12-month target$33.00$46.33$44.00$20.00
# AnalystsCovering analysts24152836
Dividend YieldAnnual dividend ÷ price+9.8%
Dividend StreakConsecutive years of raises0010
Dividend / ShareAnnual DPS$1.15
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.5%0.0%
PRGO leads this category, winning 1 of 1 comparable metric.
Key Takeaway

GLPG leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRGO leads in 2 (Valuation Metrics, Analyst Outlook). 2 tied.

Best OverallGalapagos N.V. (GLPG)Leads 2 of 6 categories
Loading custom metrics...

GLPG vs DBVT vs ALKS vs PRGO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is GLPG or DBVT or ALKS or PRGO a better buy right now?

For growth investors, Galapagos N.

V. (GLPG) is the stronger pick with 303. 5% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Galapagos N. V. (GLPG) offers the better valuation at 4. 9x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — GLPG or DBVT or ALKS or PRGO?

On trailing P/E, Galapagos N.

V. (GLPG) is the cheapest at 4. 9x versus Alkermes plc at 24. 8x.

03

Which is the better long-term investment — GLPG or DBVT or ALKS or PRGO?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: ALKS returned -11. 0% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — GLPG or DBVT or ALKS or PRGO?

By beta (market sensitivity over 5 years), Galapagos N.

V. (GLPG) is the lower-risk stock at 0. 74β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 71% more volatile than GLPG relative to the S&P 500. On balance sheet safety, Galapagos N. V. (GLPG) carries a lower debt/equity ratio of 0% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.

05

Which is growing faster — GLPG or DBVT or ALKS or PRGO?

By revenue growth (latest reported year), Galapagos N.

V. (GLPG) is pulling ahead at 303. 5% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Galapagos N. V. grew EPS 333. 0% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, GLPG leads at 66. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — GLPG or DBVT or ALKS or PRGO?

Galapagos N.

V. (GLPG) is the more profitable company, earning 28. 9% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 28. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GLPG leads at 45. 1% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is GLPG or DBVT or ALKS or PRGO more undervalued right now?

Analyst consensus price targets imply the most upside for DBVT: 131.

8% to $46. 33.

08

Which pays a better dividend — GLPG or DBVT or ALKS or PRGO?

In this comparison, PRGO (9.

8% yield) pays a dividend. GLPG, DBVT, ALKS do not pay a meaningful dividend and should not be held primarily for income.

09

Is GLPG or DBVT or ALKS or PRGO better for a retirement portfolio?

For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

18), 9. 8% yield). Both have compounded well over 10 years (PRGO: -77. 7%, DBVT: -87. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between GLPG and DBVT and ALKS and PRGO?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: GLPG is a small-cap high-growth stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while GLPG, DBVT, ALKS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

GLPG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 546%
  • Net Margin > 17%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.